Knowledge levels and associated factors about newborn care of pregnants following by hospital

AMAÇ: Bu araştırmada bir hastanenin obstetrik polikliniğinde takip edilen gebelerin yenidoğan bakımı konusundaki bilgi düzeylerinin ve etkileyen faktörlerin belirlenmesi amaçlanmıştı. GEREÇ VE YÖNTEMLER: Tanımlayıcı tipteki bu araştırma bir hastanenin Obstetrik Polikliniği’nde takipli ve araştırmaya katılmayı kabul eden 118 gebe ile yürütüldü. Araştırmanın verileri 23 soru ve iki bölümden oluşan anket formunun yüzyüze gözlem altında uygulanması yoluyla toplandı. Verilerin istatistik analizlerinde tanımlayıcı istatistikler, ki-kare ve Fisher’in kesin testi kullanıldı ve p<0.05 istatistiksel anlamlılık düzeyi olarak kabul edildi. BULGULAR: Katılımcıların %40,7’si üniversite mezunu iken, %54,2’si çalışmakta idi. Sadece %13,6’sı bebek bakımı ile ilgili eğitim almıştı. Katılımcıların %84,7’si kundaklama, %72,9’u anne sütü verme zamanı, %71,2’si gün içinde emzirilme sayısı ve %66,1’i de yenidoğana yapılacak aşılar konularında doğru bilgi sahibi idi. Yenidoğanın bakımı ile ilgili konularla eğitim düzeyi, çalışma durumu ve bebek bakımıyla ilgili eğitim alma durumu arasında anlamlı farklılık bulundu (p<0.005). SONUÇ: Araştırmamızda katılımcıların yenidoğan bakımıyla ilgili bilgi düzeyleri yüksek bulunmuştur. Eğitim düzeyi yüksek, çalışan ve bebek bakımı eğitimi almış olanların daha bilgili olmaları, ülkemizde bu konuda eğitim verilmesinin ve kadının statüsünün arttırılmasının önemini göstermektedir.OBJECTIVE: The purpose of this study was to determined knowledge levels and associated factors about newborn care of pregnants following by obstetrics policlinic of a hospital. MATERIALS AND METHODS: This descriptive study was performed with 118 voluntary pregnants following by Obstetric Policlinic of a hospital. Study data was collected by a two part questionnaire which had 23 questions by using face to face interview. The data was evaluated by descriptive statatistics, chi square and Fisher exact tests. and p<0.05 has been accepted significany level. RESULTS: Of 40.7% participants were graduated from university and 54.2% of them employed. Only 13.6% of them had an education about newborn care. 84.7% of them had correct knowledge about swaddling, 72.9% of them had correct knowledge about breastfeeding time, 71.2% of them had correct knowledge about frequency of breastfeeding in a day and 66.1% of them had correct knowledge about vaccination of the newborn. There were significant differences between newborn care knowledge and education level, employment and having an education about newborn care (p<0.005). CONCLUSION: We find newborn knowledge levels of the participants high. Participants who are high educated, employed and have an education about newborn care have more knowledge about this subject. This results show us the importance of giving education about this subject and raising status of women in our country

Safety Evaluation and Tolerability Overview of Favipiravir in the Management of COVID-19: A Real-Life Experience from Turkey

Introduction: Coronavirus diseases-2019 (COVID-19) have been ongoing for more than two years. Despite the scientific researchconducted in this process, there is still no widely accepted definitive treatment for the disease. For treating COVID-19, using antiviralagents previously used for the treatment of other RNA-virus infections has been seen as a fast way to a solution, and favipiravir is oneof the leading agents. This prospective, multicenter, observational study was designed to investigate the safety of favipiravir in 500patients treated with favipravir for favipravir.Methods: This study was conducted as a multicenter prospective study. Eight different sites from four cities participated, and 500patients were included in the study. Follow-up of laboratory parameters, adverse events (AEs), and amelioration of fever, dyspnea,and cough symptoms of the patients was recorded in a case report form.Results: A total of 475 patients from eight centers completed the study. A total of 401 AEs were reported in 206 (51.4%) patients, whichwere mild-to-moderate in the majority of cases. Serious AEs occurred in 5 patients and death occurred in 4 patients. From the first tothe last measurement, serum alanine aminotransferase levels (31.9±27.7 vs. 47.2±49.7 U/L, p&lt;0.001) increased, whereas C-reactiveprotein (39.9±66.4 vs. 15.2±30.5 mg/L, p&lt;0.001) and creatine kinase (101.7±187.7 vs. 71.9±43.5 U/L, p=0.018) levels decreased. Infollow-up parameters, oxygen saturation (SpO2; 96.2±2.7 vs. 97.5±2.1%, p&lt;0.001) and amelioration of fever (&gt;37.8 for 6.6% on day 3,3.2% on day 5, and 0.6% on day 10), dyspnea (for 56.4% on day 5, 62.4% on day 7, and 81.2% on day 10), and cough (46.0% on day 5,73.0% on day 7, and 87.3% on day 10) were noted in an increasingly higher percentage of patients with continued therapy.Conclusion: The current study provides real-life data of favipiravir, which is a unique option in Turkey for treating COVID-19 patients.The results revealed that favipiravir is a well-tolerated agent with a low side-effect profile. However, it needs to be evaluated withwell-designed, dose-compared, randomized controlled studies for the evaluation of efficacy</p

The effect of sleep disorders on quality of life in patients with epilepsy: A multicenter study from Turkey

Objective: We aimed to investigate sleep disorders in patients with epilepsy (PWE) and to investigate the effects of sleep disorders on quality of life. Methods: In our multicenter study conducted in Turkey, 1358 PWE were evaluated. The demographic and clinical data of the patients were recorded. The Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), Beck Depression Inventory (BDI), and Quality of Life in Epilepsy Inventory-10 (QOLIE-10) were administered. Results: The mean age of 1358 patients was 35.92 ± 14.11 (range, 18–89) years. Seven hundred fifty-one (55.30 %) were women. Some 12.7 % of the patients had insomnia (ISI > 14), 9.6 % had excessive daytime sleepiness (ESS > 10), 46.5 % had poor sleep quality (PSQI > 5), and 354 patients (26.1 %) had depressive symptoms (BDI > 16). The mean QOLIE-10 score was 22.82 ± 8.14 (10–48). Resistant epilepsy was evaluated as the parameter with the highest risk affecting quality of life Adjusted odds ratio (AOR = 3.714; 95 % confidence interval (CI): [2.440–5.652] < 0.001)). ISI (AOR = 1.184; 95 % CI: [1.128–1.243]; p < 0.001), ESS (AOR = 1.081; 95 % CI: [1.034–1.130]; p < 0.001), PSQI (AOR = 0.928; 95 % CI: [0.867 – 0.994]; p = 0.034), BDI (AOR = 1.106; 95 % CI: [1.084–1.129]; p < 0.001), epilepsy duration (AOR = 1.023; 95 % CI: [1.004–1.041]; p = 0.014), were determined as factors affecting quality of life. Significance: Sleep disorders are common in PWE and impair their quality of life. Quality of life can be improved by controlling the factors that may cause sleep disorders such as good seizure control, avoiding polypharmacy, and correcting the underlying mood disorders in patients with epilepsy

Incidence and clinical characteristics of acute rheumatic fever in Turkey: Results of a nationwide multicentre study

© 2021 Paediatrics and Child Health Division (The Royal Australasian College of Physicians)Aim: To evaluate the incidence and clinical features of acute rheumatic fever (ARF) in Turkey, following the revised Jones criteria in 2015. Methods: This multicentre study was designed by the Acquired Heart Diseases Working Group of the Turkish Pediatric Cardiology and Pediatric Cardiac Surgery Association in 2016. The data during the first attack of 1103 ARF patients were collected from the paediatric cardiologists between 1 January 2016 and 31 December 2016. Results: Turkey National Institute of Statistics records of 2016 were used for the determination of ARF incidence with regard to various cities and regions separately. The estimated incidence rate of ARF was 8.84/100 000 in Turkey. The ARF incidence varied considerably among different regions. The highest incidence was found in the Eastern Anatolia Region as 14.4/100 000, and the lowest incidence was found in the Black Sea Region as 3.3/100 000 (P < 0.05). Clinical carditis was the most common finding. The incidence of clinical carditis, subclinical carditis, polyarthritis, aseptic monoarthritis, polyarthralgia and Sydenham's Chorea was 53.5%, 29.1%, 52.8%, 10.3%, 18.6% and 7.9%, respectively. The incidences of clinical carditis, subclinical carditis, polyarthritis and polyarthralgia were found to be significantly different among different regions (P < 0.05). Conclusion: The findings of this nationwide screening of ARF suggest that Turkey should be included in the moderate-risk group